Figure 5.
Serum levels of VEGF, KIT, and SCF in 13 patients with GISTs with longitudinally taken serum samples available at least for 12 months. Patients with early progressive disease are shown with a bold black line (n = 5), and the rest of the patients are shown with thin lines. (A) VEGF, (B) KIT, (C) SCF.